Available Until 3/3/2024

COVID-19 Vaccines: March 2021 Update from the FDA

ACPE Activity Number: None
Release Date: March 4, 2021
Expirations Date: March 4, 2024
Activity Type: Knowledge-based  
CE Credits: None
Activity Fee: Members/Non-Member – Free


Join us as we welcome back Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research (CBER) at the FDA. He is leading efforts to make safe, effective, and transparent decisions about COVID-19 vaccine candidates. During the webinar, he will provide insight into the first few months of vaccine rollout, and what we have learned about the vaccine candidates, and the SARS-CoV-2 variants. Stay informed on the COVID-19 vaccine clinical trials and the vaccine approval process so that you can make informed decisions as the vaccine landscape continues to evolve. This activity does not offer CE credit.


  • Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research (CBER), FDA
  • Moderator: Tom Kraus, JD, Vice President of Government Relations, ASHP